Confusion prevails over Donald Trump’s plan for USrollout of coronavirus vaccine : India
As scientists and pharmaceutical companies work at breakneck speed to develop a vaccine for the novel coronavirus, public health officials and senior US lawmakers are sounding alarms about the Donald Trump administration’s lack of planning for its nationwide distribution.
The federal government traditionally plays a principal role in funding and overseeing manufacturing and distribution of new vaccines during pandemics, which often draw on scarce ingredients and need to be made, stored and transported carefully.
There won’t be enough vaccine for all 330 million Americans right away, so the government also has a role in deciding who gets it first, and in educating a vaccine-wary public about its potential life saving merits.
Right now, it is unclear who in Washington is in charge of oversight, much less any critical details, some state health officials and members of Congress told Reuters.
Last week, a senior Trump administration official told Reuters that Operation Warp Speed, a White House task force first announced here in May, was “committed to implementing the (vaccine plan and distributing medical countermeasures as fast as possible”.
However, Dr Robert Redfield, director of the Centers for Disease Control and Prevention (CDC, told a Senate hearing on July 2 that his agency would spearhead the campaign to develop and distribute a vaccine for the new coronavirus. “This is really the prime responsibility of CDC,” he said.
Republican Senator Roy Blunt, who chairs a panel overseeing health program funding, is one of several lawmakers pushing for the CDC, which was founded in 1946 to counter malaria, to lead the effort.
“They are the only federal agency with a proven track record of vaccine distribution and long-standing agreements with health departments across the country,” Blunt said in a statement in mid-July.